Topic: preventive vaccines
Univercells's new CDMO, Exothera, is hoping to play a role in helping drugmakers scale up manufacturing for a possible COVID-19 vaccine.
The scientific community has again been caught off guard and industry officials are talking about implementing better preventive measures.
Pfizer’s latest podcast is a documentary-style dive into vaccines, an eight-part series called “The Antigen” that launches in mid-December.
In a new 18-month analysis, Takeda's dengue vaccine efficacy slipped to 73.3%, down from 80% in an earlier analysis.
Merck's oncology superstar Keytruda has been stealing the spotlight, but in vaccines, the drugmaker has growth figures to tout.
IDT Biologika has a new human vaccine manufacturing facility as its narrows its focus to the development and production of human vaccines only.
With an Ebola outbreak in Congo outrunning vaccination efforts, the WHO wants to use an experimental drug from Johnson & Johnson.
As questions swirl over who knew what and when in the Philippines regarding Sanofi's dengue vaccine, the company took a chance Wednesday to pause and explain its case.
Gavi's vaccine initiative will have saved 20 million lives and $350 billion in healthcare costs by 2020, a recent study found.
A global shortage of hepatitis B vaccine has developed as both Merck & Co. and GlaxoSmithKline deal with manufacturing issues.